IGM Biosciences to Present at Three Upcoming Investor Conferences

Rhea-AI Summary

IGM Biosciences (Nasdaq: IGMS) announced that CEO Fred Schwarzer will present at three investor conferences in November 2020. The conferences are: Stifel Virtual Healthcare Conference on November 16 at 3:20 p.m. ET, Jefferies Virtual London Healthcare Conference on November 17 at 2:20 p.m. ET, and Wolfe Research Healthcare Conference on November 18 at 12:55 p.m. ET. A live webcast will be available on the company’s website, with replays accessible for 90 days after the events.

MOUNTAIN VIEW, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will present at three upcoming investor conferences:

• Stifel Virtual Healthcare Conference on Monday, November 16 at 3:20 p.m. ET.
• Jefferies Virtual London Healthcare Conference on Tuesday, November 17 at 2:20 p.m. ET.
• Wolfe Research Healthcare Conference on Wednesday, November 18 at 12:55 p.m. ET.
  

A live webcast of the events will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcasts will be archived on the Company’s website for 90 days following the presentations.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact:

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

FAQ

What conferences will IGM Biosciences present at in November 2020?

IGM Biosciences will present at the Stifel Virtual Healthcare Conference on November 16, Jefferies Virtual London Healthcare Conference on November 17, and Wolfe Research Healthcare Conference on November 18.

Who is presenting for IGM Biosciences at the investor conferences?

Fred Schwarzer, the CEO of IGM Biosciences, will present at the upcoming investor conferences.

Where can I watch the presentations from IGM Biosciences?

The live webcasts of the presentations will be available on the 'Events and Presentations' page of IGM Biosciences' website.

How long will the IGM Biosciences webcasts be available for replay?

The replays of the IGM Biosciences webcasts will be archived for 90 days following the presentations.

What is the focus of IGM Biosciences?

IGM Biosciences focuses on creating and developing engineered IgM antibodies for therapeutic use.